Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-23-048651

Chief Financial Officer bought 5,000 shares at $1.95 ($9,749)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Byam Rebecca Chief Financial Officer 2023-09-06 Purchase +5,000 $1.95 $9,749 548,946 D
Open-market purchases · 5,000 sh · avg $1.95 · $9,749
Loading xslF345X05/doc4.xml…